STABStatera Biopharma, Inc.

NASDAQ www.staterabiopharma.com


$ 0.13 $ 0.00 (1.8 %)    

Friday, 30-Sep-2022 13:29:20 EDT
QQQ $ 267.76 $ -4.61 (-1.7 %)
DIA $ 287.40 $ -4.91 (-1.68 %)
SPY $ 358.00 $ -5.61 (-1.55 %)
TLT $ 102.47 $ -1.34 (-1.29 %)
GLD $ 154.73 $ 0.01 (0.01 %)
$ 0.1298
$ 0.13
$ 0.10 x 100
$ 0.16 x 100
$ 0.13 - $ 0.13
$ 0.11 - $ 4.18
313,310
na
4.17M
$ -0.97
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-15-2021 09-30-2021 10-Q
2 08-16-2021 06-30-2021 10-Q
3 05-14-2021 03-31-2021 10-Q
4 03-22-2021 12-31-2020 10-K
5 11-16-2020 09-30-2020 10-Q
6 08-14-2020 06-30-2020 10-Q
7 05-15-2020 03-31-2020 10-Q
8 04-15-2020 12-31-2019 10-K
9 11-14-2019 09-30-2019 10-Q
10 08-14-2019 06-30-2019 10-Q
11 05-15-2019 03-31-2019 10-Q
12 03-07-2019 12-31-2018 10-K
13 11-14-2018 09-30-2018 10-Q
14 08-14-2018 06-30-2018 10-Q
15 05-15-2018 03-31-2018 10-Q
16 03-06-2018 12-31-2017 10-K
17 11-14-2017 09-30-2017 10-Q
18 08-14-2017 06-30-2017 10-Q
19 05-15-2017 03-31-2017 10-Q
20 02-22-2017 12-31-2016 10-K
21 11-14-2016 09-30-2016 10-Q
22 08-15-2016 06-30-2016 10-Q
23 05-16-2016 03-31-2016 10-Q
24 02-23-2016 12-31-2015 10-K
25 11-09-2015 09-30-2015 10-Q
26 08-12-2015 06-30-2015 10-Q
27 05-07-2015 03-31-2015 10-Q
28 02-27-2015 12-31-2014 10-K
29 11-10-2014 09-30-2014 10-Q
30 08-11-2014 06-30-2014 10-Q
31 05-12-2014 03-31-2014 10-Q
32 03-17-2014 12-31-2013 10-K
33 11-08-2013 09-30-2013 10-Q
34 08-09-2013 06-30-2013 10-Q
35 05-09-2013 03-31-2013 10-Q
36 03-18-2013 12-31-2012 10-K
37 11-09-2012 09-30-2012 10-Q
38 08-09-2012 06-30-2012 10-Q
39 05-07-2012 03-31-2012 10-Q
40 03-13-2012 12-31-2011 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 12-health-care-stocks-moving-in-tuesdays-intraday-session

Gainers

 statera-biopharma-8k-filing---companys-continued-non-compliance-could-serve-as-added-basis-for-nasdaq-delisting-gets-nasdaq-notice-on-continued-non-compliance-with-minimum-bid-price-rule-co-will-present-plan-to-regain-compliance-at-oct-6-hearing

- Dow Jones 

 12-health-care-stocks-moving-in-tuesdays-after-market-session

Gainers CinCor Pharma (NASDAQ:CINC) shares moved upwards by 19.5% to $33.0 during Tuesday's after-market session. The mar...

 stocks-that-hit-52-week-lows-on-friday

  During Friday's session, 574 stocks hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-tuesday

  On Tuesday, 250 stocks hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-monday

  On Monday, 273 companies set new 52-week lows.

 statera-biopharma-receives-anticipated-notice-of-additional-filing-delinquency-from-nasdaq

Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creat...

Core News & Articles

The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading was halted today in Statera Biopharma, Inc. (NASDAQ:STAB) at 11:0...

 12-health-care-stocks-moving-in-fridays-after-market-session

Gainers

 why-celyad-oncology-is-trading-higher-by-over-31-here-are-29-stocks-moving-premarket

Gainers MAIA Biotechnology, Inc. (NASDAQ: MAIA) rose 37.9% to $8.00 in pre-market trading after jumping 30% on Friday. The c...

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 108 companies set new 52-week lows.

 ibm-and-20-stocks-moving-premarket

Gainers Applied Blockchain, Inc. (NASDAQ: APLD) rose 32.1% to $1.40 in pre-market trading after the company reported a 200-m...

 statera-biopharma-receives-notification-letter-from-nasdaq-regarding-form-10-q-filing

  Statera Biopharma (NASDAQ:STAB) (the "Company"), a biopharmaceutical company creating next-generation immune therapi...

 analyzing-statera-biopharmas-short-interest

Statera BioPharma's (NASDAQ:STAB) short percent of float has risen 287.8% since its last report. The company recently repor...

 the-daily-biotech-pulse-fda-orphan-drug-tags-for-neurocrine-editas-candidates-sale-of-bridgebios-prv-rmat-designation-for-polaritytes-product

Here's a roundup of top developments in the biotech space over the last 24 hours: